Skip to main content
Premium Trial:

Request an Annual Quote

Digene Opens Subsidiaries in Germany, Switzerland

NEW YORK, Aug. 20 - Digene customers in Germany and Switzerland will likely find it easier to buy the company's Hybrid Capture-based molecular-diagnostic tests and equipment.

 

Gaitherburg, Md.-based Digene today said it has opened subsidiaries in those countries to help it sell its technologies there. The company said it and "third-party distributors" had previously served those markets.

 

The new facilities bring to 18 the total number of European countries in which Digene has a subsidiary, Digene said.

 

Click here for more information.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.